The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-N-benzyl-3-methyl-2-(4-(4-sulfamoylphenyl)-1H-1,2,3-triazol-1-yl)butanamide ID: ALA4460315
Chembl Id: CHEMBL4460315
PubChem CID: 59552403
Max Phase: Preclinical
Molecular Formula: C20H23N5O3S
Molecular Weight: 413.50
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)[C@H](C(=O)NCc1ccccc1)n1cc(-c2ccc(S(N)(=O)=O)cc2)nn1
Standard InChI: InChI=1S/C20H23N5O3S/c1-14(2)19(20(26)22-12-15-6-4-3-5-7-15)25-13-18(23-24-25)16-8-10-17(11-9-16)29(21,27)28/h3-11,13-14,19H,12H2,1-2H3,(H,22,26)(H2,21,27,28)/t19-/m1/s1
Standard InChI Key: CLDCKQULJFYRJV-LJQANCHMSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 413.50Molecular Weight (Monoisotopic): 413.1522AlogP: 2.11#Rotatable Bonds: 7Polar Surface Area: 119.97Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.97CX Basic pKa: ┄CX LogP: 2.73CX LogD: 2.73Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.61Np Likeness Score: -1.46
References 1. Prasher P, Sharma M.. (2019) Tailored therapeutics based on 1,2,3-1H -triazoles: a mini review., 10 (8): [PMID:31534652 ] [10.1039/C9MD00218A ]